Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria

Nav

General Info

Geography

Benin (BEN)

Kenya (KEN)

Mali (MLI)

Mozambique (MOZ)

United Republic of Tanzania (TZA)

Coverage type

Country

Time period covered

08/2006 - 03/2007

Data type

Scientific literature

Keywords

Antimalarials, Malaria

Citation

Authors

Djimdé AA, Tekete M, Abdulla S, Lyimo J, Bassat Q, Mandomando I, Lefèvre G, Borrmann S; B2303 Study Group

Journal

Antimicrob Agents Chemother

Volume

Issue

Pages

3994-9

Publication year

2011

Suggested citation

Djimdé AA, Tekete M, Abdulla S, Lyimo J, Bassat Q, Mandomando I, Lefèvre G, Borrmann S; B2303 Study Group. Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria. Antimicrob Agents Chemother. 2011; 55(9): 3994-9.

GHDx Entry last modified on: Sep 6, 2019

Header sites

Search form

Main menu

Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria

Nav